| ELVN Shares Outstanding History Table | ||||||||||||||||||||||||||
Below is a table of the ELVN shares outstanding history going back to 5/1/2023:
Also see: ELVN Market Cap History ELVN YTD Return |
As of 4/28/2026 Enliven Therapeutics has 60.90 million ELVN shares outstanding. Investors often track the ELVN shares outstanding history to compare shareholder return trends against the change in share count over time.
This page shows ELVN share count trends over time, with 12 historical shares outstanding datapoints presented, dating back to 5/1/2023.

| ELVN Shares Outstanding History Table | ||||||||||||||||||||||||||
Below is a table of the ELVN shares outstanding history going back to 5/1/2023:
Also see: ELVN Market Cap History ELVN YTD Return |
| ELVN Shares Outstanding History Chart | |||||||||||||||||||||||||||
ELVN Historical Shares Outstanding: +14.02% CAGR
Mouse over chart for data details
| |||||||||||||||||||||||||||
| ELVN Stock Price Chart |
| About Enliven Therapeutics Inc |
| Enliven Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule inhibitors to help patients with cancer. It is advancing two parallel lead product candidates, ELVN-001 and ELVN-002, and pursuing several additional research stage opportunities that align with its development approach. Its first product candidate, ELVN-001, is a potent, highly selective, small molecule kinase inhibitor designed to specifically target the breakpoint cluster region-Abelson (BCR-ABL) gene fusion, the oncogenic driver for patients with chronic myeloid leukemia. We show 12 historical shares outstanding datapoints in our coverage of ELVN's shares outstanding history. Understanding the changing numbers of ELVN shares outstanding — and comprehending the concept of differing number of shares outstanding in general comparing companies like ELVN versus peers — is critical for investors. Many "beginner" or "novice" investors will look at one stock trading at a price of $10 per share and another trading at a price of $20 per share and think the latter company is worth twice as much. Of course, that is a completely meaningless comparison without also knowing how many shares outstanding there are for each of the two companies. Furthermore, via issuance of new shares over time, or the repurchase of existing shares, the number of shares outstanding can fluctuate over the course of history. With this page we aim to empower investors researching ELVN by allowing them to research ELVN shares outstanding history as well as any other stock in our coverage universe. |
| ELVN Current Stock Quote |
Quotes delayed 20 minutes Get Dividend Alerts Get SEC Filing Alerts |
| Video: Shares Outstanding Importance | |
|
| ELVN Share Performance |
| Shares Outstanding Peers |
| Enliven Therapeutics (ELVN) is categorized under the Healthcare sector; to help you further research historical shares outstanding numbers, below are some other companies in the same sector:
ELYM Shares Outstanding History EMBC Shares Outstanding History EMMA Shares Outstanding History ENDP Shares Outstanding History ENOB Shares Outstanding History ENOV Shares Outstanding History ENSC Shares Outstanding History ENSG Shares Outstanding History ENTA Shares Outstanding History ENTO Shares Outstanding History More Healthcare companies » |
Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.2%—Every Month—Forever.
You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.2%.